 |
Articles: General Pharma |
Prior Articles
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
Amylin Pharmaceuticals, 11/02/09
Free full text
Watson Names R. Todd Joyce Senior Vice President and Chief Financial Officer; Succeeds Mark W. Durand
Watson Pharmaceuticals, 11/02/09
Free full text
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
Free full text
More Tools Launched to Handle H1N1
HealthDataManagement, 11/02/09 ACTEMRA inhibits progression of joint destruction in RA patients by over 80% compared to methotrexate alone
Chugai Pharmaceutical Co., 11/02/09
Free full text
Morphine/naltrexone extended-release capsules (Embeda): Combination of mu-opioid agonist and mu-opioid antagonist approved for the management of moderate-to-severe pain when continuous analgesia is needed for an extended time period
Formulary, 11/02/09
Free full text
BARACLUDE Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
Bristol Myers-Squibb Company, 11/02/09
Free full text
Telavancin for injection (Vibativ): Lipoglycopeptide antibiotic approved for the treatment of complicated skin and skin-structure infections
Formulary, 11/02/09
Free full text
Anti-Malignancy Agent/Anti-VEGF Humanized Monoclonal Antibody, Avastin: Application for Approval of Additional Indication of Breast Cancer
Chugai Pharmaceutical Co., 11/02/09
Free full text
Gilead Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread(R) For Chronic Hepatitis B
Gilead, 11/02/09
Free full text
Shire Reports Tolerability and Clinical Effects Results of DAYTRANA from Study in Adolescents with ADHD
Shire, 11/02/09 New Data Show Once-Daily INTUNIV Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using the Oppositional Subscale of the Conners’ ADHD Rating Scale
Shire, 11/02/09 Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C
Bristol Myers-Squibb Company, 11/02/09
Free full text
System Tracks Alzheimer's Patients
HealthDataManagement, 11/02/09 New York I.T. Group Gets New Leader
HealthDataManagement, 11/02/09 AHA Endorses E-Mail Archiver
HealthDataManagement, 11/02/09 Urinary Diversion Trends at a High Volume, Single American Tertiary Care Center
The Journal of Urology, 11/02/09 New Database to Set Out-of-Network Rates
HealthDataManagement, 11/02/09 Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds
British Journal of Clinical Pharmacology, 11/02/09 AHA Comments on Breach Rule
HealthDataManagement, 11/02/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
